Ifp Advisors, Inc Kodiak Sciences Inc. Transaction History

Ifp Advisors, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 06, 2021	SELL	$81.97 - $106.94 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$77.2 - $126.54 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$110.45 - $164.47 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	SELL	$60.78 - $154.03 $243 - $616	-4 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$45.05 - $59.27 $180 - $237	4 New	4 $0

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $288M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.